What happened
Enzychem Lifesciences updated a disclosed plan to sell treasury shares worth US$2.46M, about 4.2% of its market value.
For context, this equals about 4.2% of the company's market value.
| Disposal amount | US$2.46M |
|---|---|
| vs. market value | 4.2% |
| Filed | 2026-02-25, [Amended] Material event report (treasury share disposal) |
| Source | DART rcept 20260225003720 → open original filing |
Versions of this filing
- 2026-02-23Original
- 2026-02-24Amendment 1
- 2026-02-25Amendment 2 (this page)
Source: DART. Information only, not investment advice.

